Results 21 to 30 of about 2,455,455 (282)

Relationship between key continuous glucose monitoring-derived metrics and specific cognitive domains in patients with type 2 diabetes mellitus

BMC Neurology, 2023
Background Continuous glucose monitoring (CGM)-derived time in range (TIR) is closely associated with micro- and macrovascular complications in type 2 diabetes mellitus (T2DM).
Shanshan Dong, Lina Wang, Chenxu Zhao, Rui Zhang, Zhaoyu Gao, Lei Jiang, Yingying Guo, Huimin Zhou, Shunjiang Xu   +8 more
doaj   +1 more source

Comparison of the clinical effects of intermittently scanned and real‐time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort study

Journal of Diabetes Investigation, 2022
Aims/Introduction The aim of the study was to compare two continuous glucose monitoring (CGM) systems, intermittently scanned CGM (isCGM) and real‐time CGM (rtCGM), to determine which system achieved better glycemic control in pediatric patients ...
Tatsuhiko Urakami, Hiroki Terada, Kei Yoshida, Remi Kuwabara, Yusuke Mine, Masako Aoki, Yasuko Shoji, Junichi Suzuki, Ichiro Morioka   +8 more
doaj   +1 more source

Determination of oxygen saturation compared to a prescribed target range using continuous pulse oximetry in acutely unwell medical patients

BMC Pulmonary Medicine, 2021
Background Both inadequate and excessive administration of oxygen to acutely unwell patients results in risk of harm. Guidelines recommend titration of oxygen to achieve a target oxygen saturation (SpO2) range. Information regarding whether this is being
James C. P. Harper, Ruth Semprini, Nethmi A. Kearns, Lee Hatter, Grace E. Bird, Irene Braithwaite, Allie Eathorne, Mark Weatherall, Richard Beasley   +8 more
doaj   +1 more source

Time to Stable Therapeutic Range on Initiation of Warfarin as an Indicator of Control

, 2021
Objectives: Warfarin remains widely used with a time in therapeutic range (TiTR) above 65% recommended for best outcomes. Patients not achieving or maintaining this warfarin control may be better suited to alternate anticoagulants. Despite this, there is
Bernaitis, N, Puttasung, N, Badrick, T, Anoopkumar-Dukie, S, Davey, AK   +4 more
core   +1 more source

Retention Time and Ion Abundance Ratio of 8 Common Drugs （Poisons） by LC-MS/MS Qualitative Analysis#br# [PDF]

Fayixue Zazhi, 2020
Objective To investigate the maximum allowable deviations of retention time and ion abundance ratio of the 8 common drugs （poisons） from 3 categories, poisons （methamphetamine, morphine, ketamine）, benzodiazepines （estazolam, midazolam, diazepam ...
MIN Tao, LIU Shao-dan, XIN Guo-bin, et al.
doaj   +1 more source

Comparisons of efficacy and safety in insulin glargine and lixisenatide plus glulisine combination therapy with multiple daily injection therapy in Japanese patients with type 2 diabetes

Journal of Diabetes Investigation, 2022
Aims/Introduction Multiple daily injection therapy for early glycemic control in patients with type 2 diabetes mellitus is associated with hypoglycemia and weight gain. This study aimed to compare the efficacy (time in range of glucose level 70–180 mg/dL)
Yuji Kawaguchi, Shoko Miyamoto, Yuriko Hajika, Narumi Ashida, Koji Masumoto, Jun Sawa, Kenji Hamazaki, Yasuro Kumeda   +7 more
doaj   +1 more source

Glycaemic outcomes in adults with type 1 diabetes transitioning towards advanced automated insulin delivery systems – a real-world analysis at a Swiss tertiary centre

Swiss Medical Weekly, 2023
AIMS OF THE STUDY: To assess glucose levels in adults with diabetes at a Swiss tertiary hospital when transitioning from insulin delivery with a sensor-augmented pump with (predictive) low-glucose suspend ([P]LGS) to a hybrid-closed loop (HCL) and from ...
Vera Lehmann, Franco Noti, Markus Laimer, Christoph Stettler, Thomas Züger   +4 more
doaj   +1 more source

Integrating metabolic expenditure information from wearable fitness sensors into an AI-augmented automated insulin delivery system: a randomised clinical trial

The Lancet: Digital Health, 2023
Summary: Background: Exercise can rapidly drop glucose in people with type 1 diabetes. Ubiquitous wearable fitness sensors are not integrated into automated insulin delivery (AID) systems.
Peter G Jacobs, PhD, Navid Resalat, PhD, Wade Hilts, MS, Gavin M Young, PhD, Joseph Leitschuh, BS, Joseph Pinsonault, Joseph El Youssef, MD, Deborah Branigan, BS, Virginia Gabo, BS, Jae Eom, BS, Katrina Ramsey, MPH, Robert Dodier, PhD, Clara Mosquera-Lopez, PhD, Leah M Wilson, MD, Jessica R Castle, MD   +14 more
doaj   +1 more source

Do-It-Yourself Open Artificial Pancreas System in Children and Adolescents with Type 1 Diabetes Mellitus: Real-World Data [PDF]

Diabetes & Metabolism Journal, 2022
Few studies have been conducted among Asian children and adolescents with type 1 diabetes mellitus (T1DM) using do-it-yourself artificial pancreas system (DIY-APS). We evaluated real-world data of pediatric T1DM patients using DIY-APS. Data were obtained
Min Sun Choi, Seunghyun Lee, Jiwon Kim, Gyuri Kim, Sung Min Park, Jae Hyeon Kim   +5 more
doaj   +1 more source

A 28-nm CMOS pixel read-out ASIC for real-time tracking with time resolution below 20 ps [PDF]

, 2020
We present the development of a test ASIC, named Timespot1, designed in CMOS 28-nm technology, featuring a 32x32 pixel matrix and a pitch of 55 μm, The ASIC is conceived as the first prototype in a series, capable to read-out pixels with timing ...
Sandro Cadeddu, Piccolo, Lorenzo, Luca Frontini, Cadeddu, Sandro, Angelo Rivetti, Liberali, Valentino, Alberto Stabile, Adriano Lai, Lorenzo Piccolo, Stabile, Alberto, Frontini, Luca, Rivetti, Angelo, Lai, Adriano, Valentino Liberali   +13 more
core   +2 more sources